GlobalData on MSN

Moderna scraps mRNA vaccine in congenital CMV on Phase III failure

While development has been scrapped in CMV, a Phase II trial investigating the candidate in bone marrow transplant patients ...
PharmExec

Moderna Ceases Development of mRNA-1647 After Failing to Reach Primary Goal in Clinical Trial

Moderna announced its decision to cease development of its vaccine mRNA-1647, which was being designed to treat birth defects ...

IDWeek 2025: mRNA-1345 RSV vaccine is safe and effective in transplant recipients

Key opinion leaders previously interviewed by GlobalData noted the need for more data on current RSV vaccines and their use ...
Fierce Biotech

Arcturus’ stock halves after mRNA therapy fails to evoke efficacy in cystic fibrosis trial

In a mixed interim data drop, Arcturus Therapeutics has revealed a lack of efficacy for its investigational inhaled mRNA ...
BioSpace

Webinar: The Future of mRNA Medicine: How Advanced Data Empowers Cures

As mRNA continues to enter and be adopted by the global healthcare community, the need to quickly validate and scale these ...

Prediction: Moderna Will Soar Over the Next 5 Years. Here's 1 Reason Why.

The biotech's innovative qualities will come in handy. Long gone are the days when Moderna ( MRNA 2.66%) would generate over ...
Fierce Biotech

ESMO: Moderna's oncology efforts 'make sense' while government skeptical of vaccines

Moderna’s oncology pipeline also includes a Merck-partnered personalized cancer vaccine called intismeran autogene or ...